Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Anna Paola Fraccon"'
Autor:
Emilia Durante, Vittorina Zagonel, Antonella Facchinetti, Michele Aieta, Alberto Diminutto, Carlo Gatti, Maurizio Nicodemo, Anna Paola Fraccon, Cristina Pegoraro, Claudia Mucciarini, Alessandra Bearz, Marco Maruzzo, Francesco Massari, Vincenza Conteduca, Rita Zamarchi, Umberto Basso, Ugo De Giorgi, Carmen Barile, Elisabetta Rossi, Matteo Santoni, Pasquale Fiduccia, Alessandra Perin, Teodoro Sava
Publikováno v:
Oncologist
Background Circulating tumor cells (CTCs) correlate with adverse prognosis in patients with breast, colorectal, lung, and prostate cancer. Little data are available for renal cell carcinoma (RCC). Materials and Methods We designed a multicenter prosp
Autor:
Elisa Sottotetti, Yasmina Modena, Marina Chiara Garassino, Filippo de Braud, Luca Porcu, Ugo Pastorino, Luigi Cavanna, Giuseppe Lo Russo, Federico Nichetti, Francesca Spinnato, Manlio Mencoboni, Alessandro Del Conte, Anna Paola Fraccon, Alessandro Tuzi, Daniele Pozzessere, Rosaria Gallucci, Emanuela Vattemi, Saverio Cinieri, Claudia Proto, Francesco Verderame, Diego Signorelli, Luca Giacomelli, Carla Verri, Alessandro Bertolini, Mattia Boeri, Marco Platania, Felice Pasini, Valter Torri, Paola Antonelli, Gabriella Sozzi, Antonia Martinetti, Luciana Irtelli
Publikováno v:
Lung Cancer. 132:17-23
Background Oral vinorelbine administered at the maximum tolerated dose has already showed activity and a good safety profile in advanced non-small-cell lung cancer (NSCLC). The MA.NI.LA study was a phase II, multicenter, randomized, controlled trial
Autor:
Camillo Porta, M. Neil Reaume, Daniel Y.C. Heng, Shaan Dudani, Sumanta K. Pal, J. Connor Wells, Jae-Lyun Lee, Georg A. Bjarnason, Felice Pasini, Ravindran Kanesvaran, Christina Canil, Aaron R. Hansen, Frede Donskov, Takeshi Yuasa, Guillermo Velasco, Anna Paola Fraccon, Benoit Beuselinck, Nils Kroeger, Chun Loo Gan, Toni K. Choueiri
Publikováno v:
Dudani, S, De Velasco, G, Wells, J C, Gan, C L, Donskov, F, Porta, C, Fraccon, A, Pasini, F, Lee, J L, Hansen, A, Bjarnason, G A, Beuselinck, B, Pal, S K, Yuasa, T, Kroeger, N, Kanesvaran, R, Reaume, M N, Canil, C, Choueiri, T K & Heng, D Y C 2021, ' Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association with Survival ', JAMA network open, vol. 4, no. 1, 21869 . https://doi.org/10.1001/jamanetworkopen.2020.21869
IMPORTANCE: There exists considerable biological and clinical variability between histologic variants of metastatic renal cell carcinoma (mRCC). Data reporting on patterns of metastasis in histologic variants of mRCC are sparse. OBJECTIVE: To charact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8f6660bbbd6cebd42eff075128cbd82
https://pure.au.dk/portal/da/publications/evaluation-of-clear-cell-papillary-and-chromophobe-renal-cell-carcinoma-metastasis-sites-and-association-with-survival(71e5f952-70f6-40dc-baea-6ce7b79bed69).html
https://pure.au.dk/portal/da/publications/evaluation-of-clear-cell-papillary-and-chromophobe-renal-cell-carcinoma-metastasis-sites-and-association-with-survival(71e5f952-70f6-40dc-baea-6ce7b79bed69).html
Autor:
Jae-Lyun Lee, Camillo Porta, Christian Kollmannsberger, Christina Canil, Cosimo Sacco, Ian D. Davis, Igor Stukalin, Toni K. Choueiri, Anna Paola Fraccon, Konstantinos Koutsoukos, Takeshi Yuasa, Hao-Wen Sim, Frede Donskov, Carmel Pezaro, Wanling Xie, Nityam Rathi, Ravindran Kanesvaran, Daniel Y.C. Heng, Anders Overby, J. Connor Wells, Georg A. Bjarnason
Publikováno v:
Donskov, F, Xie, W, Overby, A, Wells, J C, Fraccon, A P, Sacco, C S, Porta, C, Stukalin, I, Lee, J-L, Koutsoukos, K, Yuasa, T, Davis, I D, Pezaro, C, Kanesvaran, R, Bjarnason, G A, Sim, H-W, Rathi, N, Kollmannsberger, C K, Canil, C M, Choueiri, T K & Heng, D Y C 2020, ' Synchronous Versus Metachronous Metastatic Disease : Impact of Time to Metastasis on Patient Outcome—Results from the International Metastatic Renal Cell Carcinoma Database Consortium ', European urology oncology, vol. 3, no. 4, pp. 530-539 . https://doi.org/10.1016/j.euo.2020.01.001
BACKGROUND: Patients with metastatic renal cell carcinoma (mRCC) may present with primary metastases (synchronous disease) or develop metastases during follow-up (metachronous disease). The impact of time to metastasis on patient outcome is poorly ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ca2dceeb24928cc37436cfced1833d7
https://pure.au.dk/portal/da/publications/synchronous-versus-metachronous-metastatic-disease(27027173-35ac-4dcc-8199-2edf53a41e16).html
https://pure.au.dk/portal/da/publications/synchronous-versus-metachronous-metastatic-disease(27027173-35ac-4dcc-8199-2edf53a41e16).html
Autor:
Pedram Argani, Cosimo Sacco, Enrico Bollito, Francesco Pierconti, Camillo Porta, Cathryn Scott, Anna Caliò, Alessandra Mosca, Guido Martignoni, Angelo Sidoni, Michele Milella, Serena Ammendola, Matteo Brunelli, Michelangelo Fiorentino, Steno Sentinelli, Luisa Canu, Serena Pedron, Simona Fisogni, Diego Segala, Anna Paola Fraccon, Enrico Munari, Andrea Remo
Summary Recently cabozantinib, a tyrosine kinase inhibitor with activity against VEGF, MET, AXL, and downregulating cathepsin K in vitro, has been proposed for the treatment of advanced clear and non-clear renal cell carcinomas. Since it is well know
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bc949f6673b336593f32ae7d708de5b
http://hdl.handle.net/10807/206241
http://hdl.handle.net/10807/206241
Autor:
Bimal Bhindi, Frede Donskov, Toni K. Choueiri, Isaac Bowman, Daniel Y.C. Heng, Christian Kollmannsberger, J. Connor Wells, Felice Pasini, Jeffrey Graham, Aaron R. Hansen, Jae-Lyun Lee, Ziad Bakouny, Brian I. Rini, Ravindran Kanesvaran, Sandy Srinivas, Anna Paola Fraccon, Sumanta K. Pal, D. Scott Ernst, Takeshi Yuasa, Naveen S. Basappa
Publikováno v:
Bhindi, B, Graham, J, Wells, J C, Bakouny, Z, Donskov, F, Fraccon, A, Pasini, F, Lee, J L, Basappa, N S, Hansen, A, Kollmannsberger, C K, Kanesvaran, R, Yuasa, T, Ernst, D S, Srinivas, S, Rini, B I, Bowman, I, Pal, S K, Choueiri, T K & Heng, D Y C 2020, ' Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma ', European Urology, vol. 78, no. 4, pp. 615-623 . https://doi.org/10.1016/j.eururo.2020.04.038
BACKGROUND: The use of cytoreductive nephrectomy (CN) selectively for patients who show a favorable response to upfront systemic therapy may be an approach to select optimal candidates with metastatic renal cell carcinoma (mRCC) who are most likely t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb237673df9d3e5ad951ded8b8ef9ef5
https://pure.au.dk/portal/da/publications/deferred-cytoreductive-nephrectomy-in-patients-with-newly-diagnosed-metastatic-renal-cell-carcinoma(13645344-f3c7-46d3-987c-a0c48f323822).html
https://pure.au.dk/portal/da/publications/deferred-cytoreductive-nephrectomy-in-patients-with-newly-diagnosed-metastatic-renal-cell-carcinoma(13645344-f3c7-46d3-987c-a0c48f323822).html
Autor:
D. Scott Ernst, I. Alex Bowman, Christian Kollmannsberger, Connor Wells, Georg A. Bjarnason, Toni K. Choueiri, Ulka N. Vaishampayan, Felice Pasini, Camillo Porta, Scott North, Anna Paola Fraccon, Benoit Beuselinck, Frede Donskov, Lori Wood, Daniel Y.C. Heng, Jeffrey Graham, Jae-Lyun Lee, Sumanta K. Pal, Sun Young Rha, Aaron R. Hansen
Publikováno v:
Graham, J, Wells, J C, Donskov, F, Lee, J L, Fraccon, A, Pasini, F, Porta, C, Bowman, I A, Bjarnason, G A, Ernst, D S, Rha, S Y, Beuselinck, B, Hansen, A, North, S A, Kollmannsberger, C K, Wood, L A, Vaishampayan, U N, Pal, S K, Choueiri, T K & Heng, D Y C 2019, ' Cytoreductive Nephrectomy in Metastatic Papillary Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium ', European urology oncology, vol. 2, no. 6, pp. 643-648 . https://doi.org/10.1016/j.euo.2019.03.007
Eur Urol Oncol
Eur Urol Oncol
BACKGROUND: There is evidence that cytoreductive nephrectomy (CN) may be beneficial in metastatic renal cell carcinoma (mRCC). This has been studied predominantly in clear-cell RCC, with more limited data on the role of CN in patients with papillary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e2d169de38e1ef48d516f2d895af2af
https://pure.au.dk/portal/da/publications/cytoreductive-nephrectomy-in-metastatic-papillary-renal-cell-carcinoma-results-from-the-international-metastatic-renal-cell-carcinoma-database-consortium(e3028cfb-15b5-4207-b836-89a0d9d1e875).html
https://pure.au.dk/portal/da/publications/cytoreductive-nephrectomy-in-metastatic-papillary-renal-cell-carcinoma-results-from-the-international-metastatic-renal-cell-carcinoma-database-consortium(e3028cfb-15b5-4207-b836-89a0d9d1e875).html
Autor:
Felice Pasini, J. Connor Wells, Neeraj Agarwal, Daniel Y.C. Heng, Hao-Wen Sim, Camillo Porta, Aristotelis Bamias, Jae-Lyun Lee, Sun Young Rha, Aly-Khan A. Lalani, Sandy Srinivas, James Brugarolas, I. Alex Bowman, Benoit Beuselinck, Brian I. Rini, Ravindran Kanesvaran, Anna Paola Fraccon, Igor Stukalin, Toni K. Choueiri, Frede Donskov
Publikováno v:
Kidney Cancer. 2:31-36
Background: Fourth-line therapy (4LT) in the treatment of metastatic renal cell carcinoma (mRCC) varies significantly due to the lack of data and recommendations to guide treatment decisions. Objective: To evaluate the use and efficacy of 4LT in mRCC
Autor:
Matteo Santoni, Francesca Maines, Sebastiano Buti, Ugo De Giorgi, Giuseppe Prati, Marco Maruzzo, Francesco Gelsomino, Maria Giuseppa Vitale, Fable Zustovich, Francesco Leonardi, Franco Morelli, Cristina Masini, Gaetano Facchini, Anna Paola Fraccon, Elena Verri, Teodoro Sava, Carmelinda Librici, Giuseppe Fornarini, Orazio Caffo, Melissa Bersanelli
Publikováno v:
Clinical Genitourinary Cancer. 15:e609-e614
Pazopanib is a standard first-line treatment for metastatic clear-cell renal cell carcinoma (ccRCC). Very few data on its activity in non-clear-cell renal cell carcinoma (nccRCC) are currently available. The aim of this study was to retrospectively a
Autor:
Claudio Codignola, Mario Scartozzi, Fausto Meriggi, Chiara Ogliosi, Giovanni Luca Ceresoli, Alberto Zaniboni, Giordano D. Beretta, Tiziana Prochilo, Alberto Caprioli, Anna Paola Fraccon
Publikováno v:
Tumori Journal. 103:443-448
Purpose Lung cancer is one of the leading causes of cancer-related death worldwide and, although targeted therapy with tyrosine kinase inhibitors has dramatically improved the rates of response and survival in advanced EGFR-mutated adenocarcinoma, th